Publications

Publications

Filter Results: (1,251) Arrow Down
Filter Results: (1,251) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 25 of 1,251 Results →
  • Research Summary

Clinical Trials as a setting for Health Policy and Management Research

The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details

    William A. Sahlman

    William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.

    Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details

    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
    • 07 Jan 2010
    • Working Paper Summaries

    International Differences in the Size and Roles of Corporate Headquarters: An Empirical Examination

    Keywords: by David Collis, David Young & Michael Goold
    • Research Summary

    Putting Patients First: Marketing Strategies for Treating HIV in Developing Nations

    It is more than mere coincidence that the highest rates of HIV occur in the world’s poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first half of this paper explores the economics of HIV and... View Details
    • Portrait Project

    Albert Chiu

    continue to inspire me. I want to reshape how vaccines and pharmaceuticals are manufactured and bring these life-saving products to patients more quickly and cheaply. From SARS to COVID-19 and beyond, I want to use my skills and education... View Details
    • November–December 2015
    • Article

    Active Postmarketing Drug Surveillance for Multiple Adverse Events

    By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
    Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical... View Details
    Keywords: Drug Surveillance; Health Care; Stochastic Models; Queueing; Diffusion Approximation; Brownian Motion; Health Care and Treatment; Analytics and Data Science; Analysis
    Related

      Stefan H. Thomke

      Stefan Thomke (sthomke@hbs.edu), an authority on the management of innovation, is the William Barclay Harding Professor of Business Administration at Harvard Business School. He has worked with firms on product, process, and... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • October 1982 (Revised May 1992)
      • Case

      Johnson & Johnson: The Tylenol Tragedy

      By: Stephen A. Greyser
      In October 1982, Johnson & Johnson was confronted with a major crisis when seven deaths were attributed to poisoned Tylenol. The case reviews the facts as known a week after the incident occurred, and raises a wide range of questions regarding consumer behavior,... View Details
      Keywords: Consumer Behavior; Corporate Social Responsibility and Impact; Competitive Strategy; Crisis Management; Health Care and Treatment; Pharmaceutical Industry
      Related
      • Web

      2023 Reunion Presentations - Alumni

      such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy enabled these changes in many ways: allowing access to telemedicine and pharmaceuticals by mail; redefining... View Details
      • Web

      Technology & Innovation - Faculty & Research

      Rickenbach made this strategic decision, describing the development of the industry and PAREXEL's place within it. Keywords: Research ; Innovation and Invention ; Business Model ; Transformation ; Globalization ; Information Technology ; Competitive Advantage ; View Details
      • 13 Jul 2020
      • Research & Ideas

      Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

      As chairman and CEO of the leading vaccine producer in the world, pharmaceutical giant Merck & Co., Ken Frazier has one of the highest-profile positions in global business. But Frazier, who is leading one of the firms on a charge to... View Details
      Keywords: by Staff; Pharmaceutical

        W. Carl Kester

        Carl Kester is a Baker Foundation Professor and the George Fisher Baker Jr. Professor of Business Administration, Emeritus at Harvard Business School. He is a member of the Finance Unit. He served as Deputy Dean for Academic Affairs (2006-2010), Chairman of the... View Details

        Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

          Paul M. Healy

          Paul Healy is the James R. Williston Professor at the Harvard Business School. His research covers a broad range of topics, including white collar crime, governance, business ethics, financial analysis, and Wall Street research. He joined the HBS faculty in 1998,... View Details

          Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals
          • 04 Jun 2013
          • Working Paper Summaries

          Prosocial Bonuses Increase Employee Satisfaction and Team Performance

          Keywords: by Lalin Anik, Lara B. Aknin, Michael I. Norton, Elizabeth W. Dunn & Jordi Quoidbach
          • 09 Oct 2020
          • Blog Post

          4 Things To Know About the MS/MBA Biotech

          and pharmaceutical management. I learned about value-based approaches to drug pricing and concluded that overseeing a mission-driven pharmaceutical company would provide me with the platform and the... View Details
          • Web

          Sample Student Projects - Institute For Strategy And Competitiveness

          Natural Gas (LNG) Cluster (2016) South Australia Wine Cluster (2010) Australia Renewable Energy (2008) Belgium Belgium Chocolate Cluster (2016) Wallonia Aeronautic Cluster (2013) Belgium Pharmaceuticals (2011) Botswana The Botswana... View Details
          • Web

          Academics - Health Care

          care organization Redesigning urgent care triage for a major academic hospital Developing a China business model for a large pharmaceutical company Cross-Registration HBS students may take graduate-level courses at several other schools... View Details
          • Web

          Health Care - Faculty & Research

          transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief... View Details

            Michael A. Wheeler

            Mike Wheeler joined the HBS faculty in 1993 and has taught extensively in its MBA, Executive, and distance learning programs. His highly interactive 8-week/40-hour HBS Online Negotiation... View Details

            Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

              Dafna Bearson

              Dafna Bearson is a doctoral candidate in the Strategy Unit at Harvard Business School. Her research interests lie at the intersection of strategy and innovation. Specifically, her research focuses on intellectual property commercialization strategy in startups... View Details

              Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals